To see your savings upside down to 0, it's a feeling be

New Post Public Reply Private Reply Replies (1) Message Board
La19 jinobi83 #3530
To see your savings upside down to 0, it's a feeling be young imagination. I've lost on stocks and recovered, thanks to many in ihub or here. Real friends who have lend me a hand. Their is good in the world today, but its like finding a diamond. I've know. Se of you personally over the years. EWSI fckd me hard, many of us are down 80%, I was a fool on many of the runs, and held in fear that if I sold I would loose the opportunity, that not only turn out to be fairy dust. I've done done much DD and supported EWSI through thick and thin. EWSI became part of me, obsess everything trung to put things together and provide support and confident, I only help to deceive unwillingly, many held cause my post.

Calculating my blindness and sitting down with accountants who do my tax's, many things came to question, which I overlooked and became blind too. I get EWSI updates, just saw my name on my mailbox going virol, wish it was for a good cause, but is not. Our leader has been in the game long enough to cube called a expert of how revenues and filings work by now. I've been fortunate to run small corporations and understand how the profit sheets work. How start ups take calculated necessary debt, in order to market the brand and eventually become profitable.

My biggest questions which lingered in my mind was Tanke, which I've been investigating since last year. Tanke was also involved with a company here in Fort Lauderdale which unvisited the location, and it was not there, nor registered with the state of Fl nor broward county occupational license debt. Tanke became associate dl with EWSI. Lots of peoples alerts went off, because the insecurity investors had over Tanke. Tanke went on a promo campaigne which launched the stock to a staggering .50 to now in the .01's. Many made a killing ad left big time bag holders wiped of. I became under the assumption Tanke was just a front company. Evotech capital associates are involved with Tanke heavily and so are EWSI associates. Meaning their in bed together, Tanke being a Chinese front company, and EWSI being a US Europe China operating company. My assumptions were that Tanke money would eventually come to EWSI, so I help through the madness. But then, EWSI felt into the battle of the Malone audits and Chinese revenues, which EWSI was pumped on in 2013. EWSI had been diluted to nothing from .05's to .0025, Somethins is going on, and it's not good. Many been in communication with The CEO, and tried to get a confirmation that an R/S won't occur, but the actual words needed have not been delivered, I don't trust this stock any longer. If I was Martin, and not an investor. I would not be at ease that my company is paying tremendous millions of dollars in professional fees every quarter. Some of you know the recycling business, and this is a huge Flag. Who is receiving this money, for what, and why, how is it counter productive to the company if were trying to make ends meet. This is a main factor which must be questioned and the truth should set the company free. Lawyers don't make that much in fees, I know plenty, accountants neither, I know plenty. So who are pay pain millions of dollars to?? No one has yet post it facts in that, and have avoided the question. If your an investor, you want answer NOW. But the board sure coats it, this is where I believe insiders come into play, one thing is to bash, another is to have questions on how the shareholders money is being out to work. Another is some Evotech associates who come into question, and have a history of opening Chinese company which have not gone any where. Pumped as dumped. Now, EWSI does have operations and I know people have have done business with them, and they also want answered which are not being touched THERALY not some Bs PR covering it up, names, locations, and for what??? Now this loan revision really topped it, more toxic under toxic, were being run to the ground. I would only hope I'm wrong, for my sake and yours. Tired of hearing about the dead cat bounce, how long has that car been thing to recover, keep beating the dead horse is what I say.

On a good note "sarcasm", if I was ambitious cold hearted CEO, the R/S would make perfect sence, take all the dilution money I can, them murder the stock and share holders to the point I can't suck any more blood, and then poof, hit the r/s and restart again, on a higher tier and them uplist.

E-Waste Systems, Inc. (EWSI) Stock Research Links

EWSI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading